Sitosterolemia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2882OMIM:210250E78.0
Who is this for?
Show terms as
3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Sitosterolemia, also known as phytosterolemia, is a rare autosomal recessive lipid metabolism disorder caused by pathogenic variants in the ABCG5 or ABCG8 genes, which encode the sterolin-1 and sterolin-2 proteins respectively. These proteins normally function as a heterodimer to limit intestinal absorption and promote biliary excretion of plant sterols (phytosterols) and shellfish sterols. In sitosterolemia, the body absorbs excessive amounts of plant sterols (such as sitosterol, campesterol, and stigmasterol) and cholesterol from the diet, and fails to excrete them adequately into bile, leading to dramatically elevated plant sterol levels in the blood and tissues. The disease primarily affects the cardiovascular system, hematologic system, and skin. Key clinical features include tendon and tuberous xanthomas (cholesterol-rich deposits under the skin and in tendons), premature atherosclerosis with risk of early coronary artery disease, and hematologic abnormalities including hemolytic anemia, macrothrombocytopenia (abnormally large platelets with low platelet counts), and stomatocytosis. Some patients may present with elevated LDL cholesterol levels, which can lead to misdiagnosis as familial hypercholesterolemia, though total cholesterol may be normal or only mildly elevated in some cases. Joint symptoms, including arthritis and arthralgias, may also occur. Age of onset is variable, with xanthomas and hematologic abnormalities sometimes appearing in childhood, though some individuals remain asymptomatic until adulthood. Diagnosis is confirmed by demonstrating elevated plasma plant sterol levels and/or genetic testing. Treatment centers on dietary restriction of plant sterols and cholesterol, combined with the medication ezetimibe, which inhibits intestinal sterol absorption. Bile acid-binding resins (such as cholestyramine) may also be used. Statins alone are generally not effective. With appropriate treatment, plant sterol levels can be significantly reduced and clinical manifestations may improve or stabilize.

Also known as:

Clinical phenotype terms— hover any for plain English:

XanthomatosisHP:0000991Giant plateletsHP:0001902StomatocytosisHP:0004446Premature coronary artery atherosclerosisHP:0005181Elevated circulating sitosterol concentrationHP:0033341MacrothrombocytopeniaHP:0040185Arthralgia/arthritisHP:0005059
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Sitosterolemia.

View clinical trials →

No actively recruiting trials found for Sitosterolemia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Sitosterolemia community →

Specialists

3 foundView all specialists →
SP
Semone B Myrie, PhD
Specialist
PI on 1 active trial
PP
Peter J Jones, PhD
Specialist
PI on 1 active trial
KP
Kong Y Chen, Ph.D.
HIGHLAND, NY
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Sitosterolemia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open SitosterolemiaForum →

No community posts yet. Be the first to share your experience with Sitosterolemia.

Start the conversation →

Latest news about Sitosterolemia

No recent news articles for Sitosterolemia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Sitosterolemia

What is Sitosterolemia?

Sitosterolemia, also known as phytosterolemia, is a rare autosomal recessive lipid metabolism disorder caused by pathogenic variants in the ABCG5 or ABCG8 genes, which encode the sterolin-1 and sterolin-2 proteins respectively. These proteins normally function as a heterodimer to limit intestinal absorption and promote biliary excretion of plant sterols (phytosterols) and shellfish sterols. In sitosterolemia, the body absorbs excessive amounts of plant sterols (such as sitosterol, campesterol, and stigmasterol) and cholesterol from the diet, and fails to excrete them adequately into bile, lead

How is Sitosterolemia inherited?

Sitosterolemia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Sitosterolemia?

3 specialists and care centers treating Sitosterolemia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.